Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 USD | -1.23% | +4.21% | -34.82% |
04-23 | Citigroup Adjusts Expensify's Price Target to $4 From $5, Keeps Buy Rating | MT |
04-17 | Expensify Insider Bought Shares Worth $466,734, According to a Recent SEC Filing | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.76 for the 2024 fiscal year.
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- Low profitability weakens the company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-34.82% | 141M | - | ||
+6.97% | 3,020B | C+ | ||
+5.80% | 82.93B | B | ||
+3.72% | 76.85B | B+ | ||
-15.18% | 53.04B | B+ | ||
+32.96% | 50.15B | D+ | ||
-25.56% | 46.71B | B- | ||
+17.43% | 41.41B | D+ | ||
+59.31% | 36.1B | D+ | ||
-10.36% | 24.64B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- EXFY Stock
- Ratings Expensify, Inc.